Skip to main content
Log in

Fludarabine significantly improves health-related quality of life (HRQOL) in elderly patients with chronic lymphocytic leukaemia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Eichhorst BF, Busch R, Hallek M, German CLL Study Group.Health related quality of life evaluated with the EORTC C30 questionnaire in first line therapy of elderly patients with chronic lymphocytic leukemia: results of a phase III trial of the German CLL Study Group (GCLLSG). Journal of Clinical Oncology 24 (Suppl.): 439s abstr. 7572, No. 18, Part 1, 20 Jun 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fludarabine significantly improves health-related quality of life (HRQOL) in elderly patients with chronic lymphocytic leukaemia. Pharmacoecon. Outcomes News 509, 8 (2006). https://doi.org/10.2165/00151234-200605090-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605090-00024

Keywords

Navigation